Last reviewed · How we verify
EC-104 high dose
At a glance
| Generic name | EC-104 high dose |
|---|---|
| Sponsor | Eclipse Life Sciences, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EC-104 high dose CI brief — competitive landscape report
- EC-104 high dose updates RSS · CI watch RSS
- Eclipse Life Sciences, Inc. portfolio CI